GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » Earnings per Share (Diluted)

Ibex Technologies (TSXV:IBT) Earnings per Share (Diluted) : C$0.15 (TTM As of Jan. 2024)


View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies Earnings per Share (Diluted)?

Ibex Technologies's Earnings per Share (Diluted) for the three months ended in Jan. 2024 was C$0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.15.

Ibex Technologies's EPS (Basic) for the three months ended in Jan. 2024 was C$0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.16.

Ibex Technologies's EPS without NRI for the three months ended in Jan. 2024 was C$0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.15.

During the past 12 months, Ibex Technologies's average EPS without NRIGrowth Rate was 181.50% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 80.10% per year.

During the past 13 years, Ibex Technologies's highest 3-Year average EPS without NRI Growth Rate was 80.10% per year. The lowest was -81.70% per year. And the median was -5.30% per year.


Ibex Technologies Earnings per Share (Diluted) Historical Data

The historical data trend for Ibex Technologies's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies Earnings per Share (Diluted) Chart

Ibex Technologies Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 0.04 0.03 0.06 0.15

Ibex Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.03 0.09 0.03 -

Competitive Comparison of Ibex Technologies's Earnings per Share (Diluted)

For the Biotechnology subindustry, Ibex Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibex Technologies's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ibex Technologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where Ibex Technologies's PE Ratio falls into.



Ibex Technologies Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Ibex Technologies's Earnings Per Share (Diluted) for the fiscal year that ended in Jul. 2023 is calculated as

Diluted Earnings Per Share (A: Jul. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(3.894-0)/25.957
=0.15

Ibex Technologies's Earnings Per Share (Diluted) for the quarter that ended in Jan. 2024 is calculated as

Diluted Earnings Per Share (Q: Jan. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(0.05-0)/24.508
=0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Ibex Technologies  (TSXV:IBT) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Ibex Technologies Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibex Technologies (TSXV:IBT) Business Description

Traded in Other Exchanges
Address
5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines